- NEWS EXPLAINER
First cell therapy for solid tumours heads to the clinic: what it means for cancer treatment
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
9,800 Yen / 30 days
cancel any time
Subscription info for Japanese customers
We have a dedicated website for our Japanese customers. Please go to natureasia.com to subscribe to this journal.
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-024-00673-w
References
Rosenberg, S. A. et al. N. Engl. J. Med. 319, 1676–1680 (1988).
Chesney, J. et al. J. Immunother. Cancer 10, e005755 (2022).
Rohaan, M. W. et al. N. Engl. J. Med. 387, 2113–2125 (2022).
Guo, J. et al. J. Immunother. Cancer 10, e003887 (2022).
Creelan, B. C. et al. Nature Med. 27, 1410–1418 (2021).